Christy Holmes
Medical · Lumberton, NCNPI 1134723802
Payments from drug & device makers
Across 132 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$620
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$288
- Corium, LLC$251
- Teva Pharmaceuticals USA, Inc.$199
- Neurocrine Biosciences, Inc.$176
- Johnson & Johnson$137
- plus $902 from 22 others
What the payments were for
- Food & beverage$2,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $620 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $288 |
| Corium, LLC | 13 | $251 |
| Teva Pharmaceuticals USA, Inc. | 10 | $199 |
| Neurocrine Biosciences, Inc. | 5 | $176 |
| Johnson & Johnson | 7 | $137 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Alkermes, Inc. | 6 | $105 |
| Supernus Pharmaceuticals, Inc. | 5 | $81 |
| E.r. Squibb & Sons, L.L.C. | 3 | $68 |
| Boston Scientific | 3 | $57 |
| Biohaven Pharmaceuticals, Inc. | 2 | $54 |
| Scilex Pharmaceuticals Inc. | 4 | $53 |
| Forte Bio-pharma LLC | 1 | $47 |
| Eisai Inc. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Braeburn Inc. | 1 | $28 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
| USWM, LLC | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Vertos Medical, Inc. | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,573 in reported general payments places this provider in the 80th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $127,965 |
| VraylarCariprazine Hcl | 74 | $108,187 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 312 | $31,960 |
| AristadaAripiprazole Lauroxil | 11 | $30,806 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 52 | $20,082 |
| TrintellixVortioxetine Hydrobromide | 20 | $9,637 |
| Aripiprazole | 131 | $6,086 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $4,710 |
| Buspirone Hcl | 154 | $2,259 |
| Hydroxyzine Hcl | 113 | $2,103 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 24 | $2,000 |
| Haloperidol Decanoate | 16 | $1,963 |
| Quetiapine Fumarate | 148 | $1,524 |
| Gabapentin | 142 | $1,412 |
| Trazodone Hcl | 167 | $1,394 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $176 | $127,96513 claims |
| AbbVieVraylar | $620 | $108,18774 claims |
| Alkermes, Inc.Aristada | $105 | $30,80611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 878 medical providers in North Carolina.
Other medical in Lumberton
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.